Poland· PL-100022688

Espumisan

A silikone product containing simeticonum, registered in Poland by Berlin-Chemie AG. The same ATC class is registered in 10 of our 19 countries.

ATC A03AX13

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEspumisanATCA03AX13REGISTER NO.PL-100022688PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Silikone is registered in 10 of 19 countries.

Countries holding a registration under ATC A03AX13 (silikone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Silikone · ATC A03AX13

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of silikone costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Silikone · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Simeticonum
Manufacturer
Berlin-Chemie AG
Country
Poland (PL)
ATC code
A03AX13
ATC class
Silikone
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990168712
  • gtin
    05909990168729
  • gtin
    05909990168736

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d28e9804-c0d6-439b-91a1-642c9b93ee36
GET /v1/drugs/d28e9804-c0d6-439b-91a1-642c9b93ee36?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki",
  "source": "urpl",
  "strength": "40 mg",
  "packaging": "05909990168712 ¦ OTC ¦ 3762\n25 kaps.\n05909990168729 ¦ OTC ¦ 3763\n100 kaps. w blistrach\n05909990168736 ¦ OTC ¦ 13433\n100 kaps. w pojemniku",
  "substance": "symetykon 40 mg",
  "common_name": "Simeticonum",
  "pl_product_id": "100022688",
  "pozwolenie_nr": "01687",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about silikone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.